Skip Navigation

This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Puig, J.G.
Right arrow Articles by Torres, R.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puig, J.G.
Right arrow Articles by Torres, R.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2004; 97: 457-458
QJM vol. 97 no. 7 © Association of Physicians 2004; all rights reserved.


Correspondence

Familial juvenile hyperuricaemic nephropathy

Sir,

In their letter to the Editor, Drs Bleyer and Hart1 raised several aspects concerning familial juvenile hyperuricaemic nephropathy (FJHN). First, they state that in QJM letter of February 2003,2 we wrote that ‘ ... an unresolved aspect of FJHN is the gene defect’, despite their having reported a mutation in the uromodulin gene (UMOD, the gene encoding the Tamm-Horsfall/uromodulin protein) in three kindreds as a cause of FJHN in December 2002.3 Our letter to QJM2 was sent on 12 November 2002. At that time, we could not be aware that a month later, Hart et al.3 would publish such a relevant contribution to the knowledge of the gene defect in FJHN, but we still apologize for our oversight in not mentioning them.

Second, Drs Bleyer and Hart's experience agrees with the observation that allopurinol does not halt or diminish renal deterioration, in contrast to that of Fairbanks et al.4 Our experience with 12 patients belonging to three families also indicates that allopurinol does not exert a nephroprotective effect in FJHN.5

Third, the authors state that ... it would be most useful to know if uromodulin mutations are responsible for FJHN in the families reported by Puig’.1 We are grateful for the opportunity to communicate that we have diagnosed five Spanish families as ‘having familial nephropathy associated with hyperuricemia’.6 This term was chosen because we questioned the pathogenic relevance of increased serum urate levels in FJHN.7 Of these five families,6 one refused genetic testing, one did not have a UMOD mutation, and three contributed to the confirmation by Turner et al.8 of the UMOD mutation as the cause of FJHN.

Whether the UMOD mutation is a unique characteristic and pathogenic feature of FJHN is uncertain. Recently, Dahan et al.9 reported a cluster of UMOD mutations in 11 FJHN families (10 missense and one in-frame deletion). By examining urine samples and renal biopsies, these authors concluded that UMOD mutations led to aberrant expression and accumulation of the protein within the intracellular epithelia of the thick ascending limb of the loop of Henle. This could affect urate transport through a decrease in sodium chloride reabsorption, and the latter would induce a state of volume contraction, thereby enhancing proximal urate reabsorption and causing hyperuricaemia. UMOD mutations have also been described in families with the autosomal-dominant form of medullary cystic kidney disease (MCKD2).3,10 and in families with the disease complex MCKD/FJHN.11 However, several other families that apparently have the clinical characteristics of FJHN have not shown UMOD mutations, lending support to the possibility of genetic heterogeneity in FJHN. In fact, a hepatocyte nuclear factor-1ß gene mutation has been described as associated with diabetes and FJHN.12 Thus, we believe that an adequate and precise phenotype–genotype classification of patients showing hyperuricaemia, decreased urinary uric acid excretion, young-onset gout, kidney cystic disease and renal impairment is necessary to increase our knowledge on these familial nephropathies, before we can establish a precise diagnosis for individual patients.

--> J.G. Puig and R.J. Torres

‘La Paz’ University Hospital Madrid Spain e-mail:jgarciapuig{at}navegalia.com

References

1. Bleyer AJ, Hart TC. Familial juvenile hyperuricaemic nephropathy. Q J Med 2003; 96:867–8.

2. Puig JG, Torres RJ. Familial juvenile hyperuricaemic nephropathy. Q J Med 2003; 96:172–3.

3. Hart TC, Gorry MC, Hart PS, Woodard AS, Shihabi Z, Sandhu J, Shirts B, Xu L, Zhu H, Barmada MM, Bleyer AJ. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 2002; 39:882–92.[Abstract/Free Full Text]

4. Fairbanks LD, Cameron JS, Venkat-Raman G, Rigden SPA, Rees L, Van’t Hoff W, Mansell M, Pattison J, Goldsmith DJA, Simmonds HA. Early treatment with allopurinol in familial juvenile hyperuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. Q J Med 2002; 95:597–607.

5. Miranda MaE on behalf of the Spanish group for the study of FNAH. The influence of allopurinol on renal deterioration in familial nephropathy associated with hyperuricemia (FNAH). Adv Exp Med Biol 1995; 370:61–4.

6. Puig JG, Miranda ME, Mateos FA, Picazo ML, Jiménez ML, Calvin TS, Gil AA. Hereditary nephropathy associated with hyperuricemia and gout. Arch Intern Med 1993; 153:357–65.[Abstract]

7. Mateos FA, Puig JG on behalf of the Spanish group for the study of FNAH. Renal hemodynamic in familial nephropathy associated with hyperuricemia (FNAH). Adv Exp Med Biol 1995; 370:31–4.

8. Turner JJ, Stacey JM, Harding B, Kotanko P, Lhotta K, Puig JG, Roberts I, Torres RJ, Thakker RV. Uromodulin mutations cause familial juvenile hyperuricaemic nephropathy. J Clin Endocrinol Metab 2003; 88:1398–401.[Abstract]

9. Dahan K, Devuyst O, Smaers M, et al. A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol 2003; 14:2883–93.[Abstract/Free Full Text]

10. Wolf MT, Mucha BE, Attanasio M, Zalewski I, Karle SM, Neumann HP, Rahman N, Bader B, Baldamus CA, Otto E, Witzgall R, Fuchshuber A, Hildebrandt F. Mutations of the uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains. Kidney Int 2003; 64: 1580–7.[CrossRef][ISI][Medline]

11. Rampoldi L, Caridi G, Santon D, Boaretto F, Bernascone I, Lamorte G, Tardanico R, Dagnino M, Colussi G, Scolari F, Ghiggeri GM, Amoroso A, Casari G. Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. Hum Mol Genet 2003; 12: 3369–84.[Abstract/Free Full Text]

12. Bingham C, Ellard SE, vant Hoff WG, Simmonds HA, Marinaki AM, Badman MK, Winocour PH, Stride A, Lockwood CR, Nicholls AJ, Owen KR, Spyer G, Pearson ER, Hattersley AT. Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1ß gene mutation. Kidney Int 2003; 63:1645–51.[CrossRef][ISI][Medline]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Puig, J.G.
Right arrow Articles by Torres, R.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puig, J.G.
Right arrow Articles by Torres, R.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?